Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections

• Conditions: Viral Infection; Bacterial Infections

• Registration Number: NCT03846921
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

This study aims to investigate the use of alpha-defensin as a diagnostic means to distinguish between acute bacterial and viral infections.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-02
• Study First Submitted: 2019-02-18
• Study First Submitted QC: 2019-02-18
• Study First Posted: 2019-02-20
• Study Start: 2019-03-04
• Last Update Submitted: 2019-03-06
• Last Update Posted: 2019-03-08
• Primary Completion: 2020-03
• Study Completion: 2020-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Children with either bacterial or viral infections

Exclusion Criteria

• All others

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rise in alpha-defensin	One year	Laboratory blood tests will be analyzed to determine whether there is a rise in alpha-defensin levels in bacterial infections as compared to viral infections.

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel